Tilray Inc (TLRY)
Tilray Brands, Inc. is a Nasdaq-listed common equity issued by a healthcare sector company focused on consumer products and cannabis-related businesses. The company is involved in the research, cultivation, processing, and distribution of medical cannabis in Canada, the United States, Europe, the Middle East, Africa, and other international markets. Its operations are organized across four segments: Beverage, Cannabis, Distribution, and Wellness. Tilray also markets medical and adult-use cannabis products, distributes pharmaceutical and wellness products, and produces beverage and hemp-based food products. In addition, it offers entertainment products. The company sells through a broad range of channels, including retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, governments, and direct-to-consumer customers. Headquartered in Leamington, Canada, the company was formerly known as Tilray, Inc. before adopting the Tilray Brands, Inc. name in January 2022.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-TLRY
|
$6.17
|
44.4% Upside
|
Undervalued
|
$9.05
|
111.7% Upside
|
Bargain
|
Fair
|
—
|
—
|
—
|
0.0%
|
July 24, 2026
|
-0.4x
|
0.3x
|
0.6x
|
504.6 M
|
567.1 M
|
40.6%
|
99.3%
|
-4.2
|
—
|
5.5%
|
